Commercial Bovine Proteoglycan Is Highly Arthritogenic and Can Be Used as an Alternative Antigen Source for PGIA Model
Figure 1
Arthritis incidence (a) total clinical score (b) and maximum clinical score (c) in mice with bovine proteoglycan-induced arthritis. Female BALB/c retired breeder mice were immunized with three doses of bovine PG associated with DDA adjuvant, 21-day interval. Clinical score was daily evaluated after the third immunization. compared to control.